Intensity Therapeutics, Inc. (INTS)
0.5273
+0.03
(+5.14%)
USD |
NASDAQ |
Dec 09, 16:00
0.5266
0.00 (0.00%)
Pre-Market: 08:54
Intensity Therapeutics Market Cap: 31.67M for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Harvard Bioscience, Inc. | 32.12M |
| Moleculin Biotech, Inc. | 13.72M |
| NovaBay Pharmaceuticals, Inc. | 228.08M |
| Palatin Technologies, Inc. | 25.56M |
| Theriva Biologics, Inc. | 7.524M |
Market Cap Related Metrics
| Price to Book Value | 4.386 |
| Price | 0.5273 |
| Earnings Yield | -120.3% |